In conclusion, using conscious animals we have demonstrated that PARP-1 participates in dyslipidemia-mediated vascular dysfunction and dysregulation of autonomic function and that PARP-1 gene deletion is protective against these defects. Here, PARP1 is linked to metabolic syndrome.